{
  "paper": {
    "doi": null,
    "pmcid": "PMC11729088",
    "title": "Targeted demethylation of the BRD7 promoter based on CRISPR/dCas9 system inhibits the malignant progression of nasopharyngeal carcinoma",
    "authors": [
      "Ming Zhou",
      "Jianxia Wei",
      "Mengna Li",
      "Yumei Duan",
      "Changning Xue",
      "Lemei Zheng",
      "Qingqing Wei",
      "Zubing Wu",
      "Huizhen Xin",
      "Ting Zeng",
      "Hongyu Deng",
      "Songqing Fan",
      "Wei Xiong",
      "Zhaoyang Zeng"
    ],
    "journal": "Clinical and Translational Medicine",
    "year": 2024,
    "study_type": "experimental",
    "eco_type": "in_vitro_in_vivo"
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "39f1b7e43865f4ea820908097aed6859daeae7cf",
      "git_commit_short": "39f1b7e",
      "git_branch": "ingest-refactor",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:f94cc0ab23940d18"
    },
    "execution": {
      "timestamp": "2026-02-23T18:23:43.991397Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 34.75
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "BRD7",
      "class": "Gene",
      "name": "BRD7",
      "synonyms": [
        "bromodomain containing 7"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1103",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "NPC",
      "class": "Disease",
      "name": "nasopharyngeal carcinoma",
      "synonyms": [
        "NPC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0027442",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "CRISPR_dCas9",
      "class": "Drug",
      "name": "CRISPR/dCas9 system",
      "synonyms": [
        "dCas9",
        "nuclease-deficient Cas9"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "TET1CD",
      "class": "Gene",
      "name": "TET1 catalytic domain",
      "synonyms": [
        "TET1CD"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:25941",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "decitabine",
      "class": "Drug",
      "name": "decitabine",
      "synonyms": [
        "5-Aza-2'-deoxycytidine",
        "5-AZA-CdR"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "3002",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "hypermethylation",
      "class": "Phenotype",
      "name": "hypermethylation",
      "synonyms": [
        "DNA hypermethylation"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C1512554",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "cell_proliferation",
      "class": "Phenotype",
      "name": "cell proliferation",
      "synonyms": [
        "proliferation"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0596290",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "tumor_suppressor",
      "class": "Phenotype",
      "name": "tumor suppressor",
      "synonyms": [
        "tumour suppressor"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0597611",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "PI3K_AKT",
      "class": "Pathway",
      "name": "PI3K/AKT pathway",
      "synonyms": [
        "PI3K/AKT signaling"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "ERK",
      "class": "Pathway",
      "name": "ERK pathway",
      "synonyms": [
        "ERK signaling"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "PMC11729088:abstract:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC11729088",
      "text_span_id": "abstract_1",
      "text": "BRD7 has been confirmed to be lowly expressed in nasopharyngeal carcinoma (NPC) tissues and exerts tumour suppressive roles",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "in_vitro_in_vivo",
      "source": "extracted"
    },
    {
      "id": "PMC11729088:abstract:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC11729088",
      "text_span_id": "abstract_2",
      "text": "There was hypermethylation modification in BRD7 promoter, which was negatively correlated with BRD7 expression",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "in_vitro_in_vivo",
      "source": "extracted"
    },
    {
      "id": "PMC11729088:results:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC11729088",
      "text_span_id": "results_1",
      "text": "all five sgRNA-guided CRISPR/dCas9 systems could activate BRD7 and inhibit cell proliferation to varying degrees, among which sgRNA2&sgRNA5 were the most significant",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "in_vitro",
      "source": "extracted"
    },
    {
      "id": "PMC11729088:results:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC11729088",
      "text_span_id": "results_2",
      "text": "both sgRNA2&sgRNA5 could promote the transcriptional activation by reducing its methylation, and inhibit the cell proliferation, migration, invasion and tumour growth in vivo of NPC",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "in_vitro_in_vivo",
      "source": "extracted"
    },
    {
      "id": "PMC11729088:introduction:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "PMC11729088",
      "text_span_id": "introduction_1",
      "text": "BRD7 was confirmed to be down-expressed in NPC and acts as a tumour suppressor in NPC by negatively regulating signalling pathways like ERK, Rb/E2F and PI3K/AKT",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "experimental",
      "eco_type": "in_vitro",
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "BRD7",
      "predicate": "ASSOCIATED_WITH",
      "object": "tumor_suppressor",
      "evidence_ids": [
        "PMC11729088:abstract:1:llm",
        "PMC11729088:introduction:1:llm"
      ],
      "source_papers": [
        "PMC11729088"
      ],
      "confidence": 0.95,
      "properties": {
        "relationship_type": "functional"
      },
      "section": "abstract",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "BRD7",
      "predicate": "DECREASES",
      "object": "NPC",
      "evidence_ids": [
        "PMC11729088:abstract:1:llm"
      ],
      "source_papers": [
        "PMC11729088"
      ],
      "confidence": 0.95,
      "properties": {
        "relationship_type": "expression"
      },
      "section": "abstract",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "hypermethylation",
      "predicate": "DECREASES",
      "object": "BRD7",
      "evidence_ids": [
        "PMC11729088:abstract:2:llm"
      ],
      "source_papers": [
        "PMC11729088"
      ],
      "confidence": 0.95,
      "properties": {
        "relationship_type": "epigenetic_regulation"
      },
      "section": "abstract",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "CRISPR_dCas9",
      "predicate": "INCREASES",
      "object": "BRD7",
      "evidence_ids": [
        "PMC11729088:results:1:llm"
      ],
      "source_papers": [
        "PMC11729088"
      ],
      "confidence": 0.95,
      "properties": {
        "relationship_type": "therapeutic_activation"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "CRISPR_dCas9",
      "predicate": "DECREASES",
      "object": "cell_proliferation",
      "evidence_ids": [
        "PMC11729088:results:1:llm",
        "PMC11729088:results:2:llm"
      ],
      "source_papers": [
        "PMC11729088"
      ],
      "confidence": 0.95,
      "properties": {
        "relationship_type": "therapeutic_effect"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "BRD7",
      "predicate": "REGULATES",
      "object": "PI3K_AKT",
      "evidence_ids": [
        "PMC11729088:introduction:1:llm"
      ],
      "source_papers": [
        "PMC11729088"
      ],
      "confidence": 0.95,
      "properties": {
        "relationship_type": "pathway_regulation"
      },
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "BRD7",
      "predicate": "REGULATES",
      "object": "ERK",
      "evidence_ids": [
        "PMC11729088:introduction:1:llm"
      ],
      "source_papers": [
        "PMC11729088"
      ],
      "confidence": 0.95,
      "properties": {
        "relationship_type": "pathway_regulation"
      },
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "CRISPR_dCas9",
      "predicate": "TREATS",
      "object": "NPC",
      "evidence_ids": [
        "PMC11729088:results:2:llm"
      ],
      "source_papers": [
        "PMC11729088"
      ],
      "confidence": 0.9,
      "properties": {
        "relationship_type": "therapeutic"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    }
  ],
  "notes": [
    "This study demonstrates a novel CRISPR/dCas9-based targeted demethylation approach for reactivating the tumor suppressor gene BRD7 in nasopharyngeal carcinoma",
    "The research shows both in vitro and in vivo evidence for the therapeutic potential of this epigenetic editing approach",
    "Clinical correlation between BRD7 hypermethylation and expression levels supports the translational relevance of this work"
  ]
}